Top Markets
Coin of the day
Joyzyme Group Limited Joyzyme Group Limited

Joyzyme Group Limited

8622
Classement en actions #32054
Huakang Biomedical Holdings Company Limited operates as an investment holding... Huakang Biomedical Holdings Company Limited operates as an investment holding firm, primarily dedicated to the research, development, manufacturing, marketing, and distribution of in-vitro diagnostic (IVD) reagents within the People's Republic of China. Its comprehensive product portfolio encompasses IVD reagents designed for assessing male and female fertility, detecting parasite antibodies, and identifying the Epstein-Barr virus. Additionally, the company provides auxiliary reproductive supplies and equipment, alongside a range of healthcare products and nutritional supplements marketed under its 'Nutronic' brand, which are sold through both digital and physical platforms. Products are distributed directly to hospitals and medical institutions, as well as through a network of third-party distributors. The company was founded in 1992 and maintains its headquarters in Wan Chai, Hong Kong.
Prix de l'action
$0.02174746
Capitalisation boursière
$11.21M
Changement (1 jour)
-0.58%
Changement (1 an)
-55.25%
Pays
HK
Échange Joyzyme Group Limited (8622)

Catégorie

Ratio P/B pour Joyzyme Group Limited (8622)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de Joyzyme Group Limited, le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour Joyzyme Group Limited de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes